Skip to main content

Copper Peptide Bioavailability

Meaning

Copper Peptide Bioavailability refers to the degree and rate at which a specific copper-binding peptide, typically Glycyl-L-Histidyl-L-Lysine (GHK-Cu), is absorbed into the systemic circulation or a target tissue and becomes available to exert its biological effects. Clinically, optimizing this parameter is essential to maximize the therapeutic potential of the peptide, particularly its documented roles in tissue remodeling, anti-inflammatory action, and antioxidant defense. The measurement ensures that the administered dose effectively reaches the cellular receptors and enzymatic systems to drive the desired physiological outcome.